Skip to Main Content
An official website of the United States government
Epidemiology and Genomics Research Program

March 2023 EGRP Cancer Epidemiology News

EGRP Cancer Epidemiology News

March 2023

NCI Seeks Associate Director, Epidemiology and Genomics Research Program

NCI is seeking an innovative leader to serve as the Associate Director, Epidemiology and Genomics Research Program (EGRP) in the Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI), and report directly to the Director, DCCPS.

The mission of DCCPS is to provide national and international leadership in supporting research in surveillance, epidemiology, health services, behavioral science, and cancer survivorship with the goal of reducing the burden of cancer in America. For more information about the division, go to https://cancercontrol.cancer.gov.

The Associate Director coordinates the development and implementation of the mission of EGRP to advance innovative research in human populations, to understand determinants of cancer occurrence and outcomes, and to translate findings to clinical and public health interventions.

The Associate Director would establish the scientific and strategic priorities for the program and advance the activities of five unique branches by allocating resources, staff, and assignments. The Associate Director also oversees the large-scale prospective cancer epidemiology cohorts, a rich resource of data and biospecimen collections from diverse populations, with great potential for innovative research into cancer risks and outcomes following cancer diagnosis.

Specifically, the Associate Director is responsible for leading EGRP management and operations, including research budget planning and execution, grant portfolio management, and communications; overseeing a $200M research portfolio of approximately 300 grants, as well as interagency agreements, contracts, and numerous partnership initiatives; the implementation of numerous scientific initiatives in areas including, but not limited to, metabolic dysregulation and cancer risk, new cohorts to assess environmental exposures and cancer risk, patient engagement and cancer genome sequencing, cannabis and cannabinoid use in adult cancer patients during treatment, and climate change; approximately 45 scientific and administrative staff, supervising seven staff members directly; and facilitating collaborations including with the National Institutes of Health Institutes and Centers, the Centers for Disease Control and Prevention, and many non-governmental organizations.

The successful candidate will have

  • a PhD or MD in an academic field related to the health sciences or allied sciences appropriate to the work of this position and equivalent experience,
  • expertise in cancer epidemiology and genomics research that will enable management of innovative epidemiology and genomics research programs in human populations designed to understand determinants of cancer occurrence and outcomes and translate findings to clinical and public health interventions,
  • expert knowledge of current advances and developments in cancer epidemiology and genomics research to advise NCI leadership on emerging trends and future research,
  • strong fiscal responsibility, an understanding of new trends in cancer research, awareness of the complex challenges facing cancer control and population research, and the ability to collaborate within and between complex organizations, and
  • supervisory experience in managing high-level scientists and administrative staff.

More details about this position, and how to apply, are available at https://service.cancer.gov/nci-scss.do#/vacancy/473a2c401b9da9101ef920eae54bcb52.

Please contact Kelly Barch (kelly.barch@nih.gov) if you have questions about this position.

Funding Opportunities

  • RFA-CA-23-025, Addressing the Primary Care Needs of Cancer Survivors (U01, Clinical Trial Required)
  • RFA-OD-23-013, Understanding Chronic Conditions Understudied Among Women (R21, Clinical Trial Optional)
  • RFA-OD-23-014, Understanding Chronic Conditions Understudied Among Women (R01, Clinical Trial Optional)
  • PAR-23-124, Genomic Community Resources (U24, Clinical Trial Not Allowed)
  • PAR-23-035, Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01, Clinical Trial Not Allowed)
  • PAR-23-109, NIH Medical Scientist Partnership (FM1, Clinical Trial Not Allowed)
  • PAR-23-116, Centers for AIDS Research (P30, Clinical Trial Not Allowed)
  • PAR-23-117, Developmental Centers for AIDS Research (P30, Clinical Trial Not Allowed)
  • NOT-CA-23-044, Notice of Special Interest (NOSI): Administrative Supplement to Support Health Policy Research in Cancer Prevention and Control
  • NOT-CA-23-048, NOSI: Enhancement of External Environmental Exposure Assessment for Cancer Epidemiology Research
  • NOT-CA-23-046, NOSI: Administrative Supplements to Conduct Systematic Evidence Reviews on the Clinical Utility of Cancer Site-Specific Polygenic Risk Scores for Cancer Risk Assessment
  • NOT-CA-23-032, NOSI: Administrative Supplements to Initiate or Augment Outreach to and Inclusion of Sexual and Gender Minority Populations
  • NOT-CA-23-041, NOSI: Administrative Supplements to Examine the Effects of Digital Tools and Interventions on Patient-Provider Communication Across the Cancer Control Continuum
  • NOT-CA-23-037, NOSI: Technology Development for Cancer Control and Population Science Research
  • NOT-HD-23-006, NOSI: Climate Change and Health Administrative Supplements
  • NOT-OD-23-082, NOSI: Administrative Supplements to Support Collaborations to Improve AI/ML -Readiness of NIH-Supported Data
  • NOT-OD-23-073, NOSI: Administrative Supplements to Enhance Software Tools for Open Science
  • NOT-OD-23-070, NOSI: Administrative Supplements to Support the Exploration of Cloud in NIH-supported Research
  • NOT-OD-23-083, NOSI: Administrative Supplement for Research Efforts that Elucidate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)
  • NOT-RM-23-005, NOSI: Research Supplements to Promote Workforce Diversity and Enhance Utility and Use of Common Fund Datasets
  • NOT-OD-23-099, Notice of Intent to Publish a Funding Opportunity Announcement for Established Data Repositories and Knowledgebases (Clinical Trials Not Allowed)
  • NOT-OD-23-089, Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Behavioral and Social Science through Ontology Development and Use (U01)
  • NOT-OD-23-090, Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Behavioral and Social Science through Ontology Development and Use (U24)

Grants Policy Announcements

  • NOT-OD-23-095, Expiration of the COVID-19 Public Health Emergency
  • NOT-OD-23-097, NIH Can No Longer Grant Common Rule Exceptions to the Use of a Single IRB for Multi-Site Research After the COVID-19 Public Health Emergency Expiration Date of May 11, 2023
  • NOT-OD-23-086, Updated Process for Requesting Drawdowns Outside of the Liquidation Period
  • NOT-OD-23-102, Guidance for the Repayment of Grant Funds

Requests for Information

  • NOT-CA-23-023, Existing Data Sharing Processes for NIH-Funded Research (responses requested by April 3, 2023)
  • NOT-OD-23-084, Re-envisioning US Postdoctoral Research Training and Career Progression within the Biomedical Research Enterprise (responses requested by April 14, 2023)
    Note: NIH is holding listening sessions in March. View details and registerExternal Web Site Policy
  • NOT-OD-23-091, NIH Plan to Enhance Public Access to the Results of NIH-Supported Research (responses requested by April 24, 2023)

Career and Training Opportunities

News and Blog Posts

Stay Connected

Subscribe for Updates

Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.

Subscribe to the E-Newsletter

Need Help?

EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.

Email Us
(240) 276-6730
Last Updated: 16 Mar, 2023